Impacto de la enfermedad renal avanzada del trasplantado renal y su vuelta a diálisis

Cubero, Juan José; Fresnedo, Gema Fernández; Luna, Enrique; Hernández-Gallego, Román; Arias, Manuel
February 2009
Nefrologia;Feb2009 Supplement, Vol. 29 Issue S1, p3
Academic Journal
Although long-term outcomes also improved, graft loss caused by chronic allograft nephropathy remains an important obstacle. This situation, together with the progressive increase in the number of renal transplant patients, means that the population of transplant patients readmitted to a dialysis program will be progressively greater. The mortality rate in patients starting dialysis after graft loss has been reported as variable, though higher than that observed in patients with a functioning graft and that observed in patients on dialysis treatment. However, it is not known how the management of chronic kidney disease patients in the transplant setting differs from that of patients with native kidney disease with a similar degree of renal dysfunction. Many patients in stages 4T-5T have chronic kidney disease related complications that fall below targets established for nontransplant chronic kidney disease patients. A limited number of studies have evaluated patients returning to dialysis after graft failure and the different guidelines in the setting of transplantation have not analyzed this crucial aspect so important. Parting from this premise, a working group of the Spanish Society of Nephrology in the field of kidney transplantation and dialysis has reviewed in-depth each of the clinical aspects of care of patients with kidney transplant failure coming back to dialysis and drawn up a consensus document in order to optimize the management of this condition.


Related Articles

  • Pathogenesis and Management of Chronic Allograft Nephropathy. Yilmaz, Serdar; Sar, Aylin // Drugs;2008 Supplement 1, Vol. 68, p21 

    Chronic allograft nephropathy (CAN) is a common cause of late kidney transplant failure, characterized by progressive histological damage in the allograft. Although functional biomarkers such as creatinine are typically used to predict CAN, recent evidence suggests that composite, quantitative...

  • Pharmacotherapeutic Approach to Prevent or Treat Chronic Allograft Nephropathy. Scholten, E.M.; de Fijter, J.W.; Paul, L.C. // Current Drug Targets - Cardiovascular & Haematological Disorders;Dec2002, Vol. 2 Issue 2, p79 

    In the current paper we will review the evidence that drug therapy may be of value to prevent or treat chronic allograft nephropathy. We will review the immunosuppressive therapy and non-immune therapies in use to treat risk factors associated with chronic allograft nephropathy and evaluate...

  • First examination of ACE inhibition in chronic allograft nephropathy in humans.  // Kidney;Sep/Oct2002, Vol. 11 Issue 5, p222 

    Presents a summary of the study 'Angiotensin Converting Enzyme Inhibition in Chronic Allograft Nephropathy,' by J. Lin, A.M. Valeri et al., from a 2002 issue of 'Transplantation.'

  • Kidney.  // Laboratory Investigation (00236837);Jan2006 Supplement, Vol. 86, p258A 

    Several abstracts related to kidney diseases are presented including "Routine Immunohistochemical Screening of All Renal Transplant Biopsies for Polyomavirus," by K. O. Alsaad, E. C. Belanger, E. C. Cole and A. M. Herzenberg, "DeNovo Light Chain Deposition Disease in the Renal Allograft," by J....

  • End-stage kidney disease due to haemolytic uraemic syndrome - outcomes in 241 consecutive ANZDATA registry cases. Wen Tang; Mohandas, Janaki; McDonald, Stephen P; Hawley, Carmel M; Badve, Sunil V; Boudville, Neil; Brown, Fiona G; Clayton, Philip A; Wiggins, Kathryn J; Bannister, Kym M; Campbell, Scott B; Johnson, David W // BMC Nephrology;2012, Vol. 13 Issue 1, p164 

    Background: The aim of this study was to investigate the characteristics and outcomes of patients receiving renal replacement therapy for end-stage kidney disease (ESKD) secondary to haemolytic uraemic syndrome (HUS). Methods: The study included all patients with ESKD who commenced renal...

  • Planning and Fiscal Responsibility Will Better Assist Patients With Costs. Neyhart, Clara // Nephrology Nursing Journal;Mar/Apr2004, Vol. 31 Issue 2, p221 

    Focuses on the need for planning and fiscal responsibility in assisting renal disease patients with the cost of transplantation in the U.S. Goal of transplantation; Percentage of medications covered by the Medicare; Role of the nephrology health care community in the containment of medical costs.

  • Serum β2-microglobulin at discharge predicts mortality and graft loss following kidney transplantation. Astor, Brad C; Muth, Brenda; Kaufman, Dixon B; Pirsch, John D; Michael Hofmann, R; Djamali, Arjang // Kidney International;Oct2013, Vol. 84 Issue 4, p810 

    Serum β2-microglobulin (β2M), a novel marker of kidney function, predicts mortality and kidney failure in the general population, and its elevation following transplantation is a marker of acute rejection. The association between post-transplant serum β2M and outcomes following kidney...

  • The mortality risk with graft function has decreased among children receiving a first kidney transplant in the United States. Laskin, Benjamin L; Mitsnefes, Mark M; Dahhou, Mourad; Zhang, Xun; Foster, Bethany J // Kidney International;Mar2015, Vol. 87 Issue 3, p575 

    Mortality has decreased in children with end-stage kidney disease. Decreases in mortality during dialysis and improved graft survival contributed to this improvement. However, it is unknown whether rates of death with graft function have also improved. We measured this in first transplant...

  • ORGAN-TRANSPLANTATION: A SOCIETAL PROBLEM. Simmons, Roberta G.; Simmons, Richard L. // Social Problems;Summer71, Vol. 19 Issue 1, p36 

    As a new medical technology, organ-transplantation has created unanticipated adjustment problems for the government, the general public, medical organization, and the patient and his family. This article discusses some of these problems with a focus on kidney transplantation since renal...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics